FDA Authorizes Monoclonal Antibodies for COVID-19 Treatment

US FDA issued an emergency use authorization for casirivimab and imdevimab for treatment of mild to moderate COVID-19.

from Medindia Health News https://ift.tt/3fBIRZQ